---
title: "GLYNN MICHAEL — Ownership Dossier"
canonical: https://whiteintel.dev/entity/df522c7a-e48e-5f91-9ca6-42e06fe7e79e
json: https://whiteintel.dev/api/public/dossier/df522c7a-e48e-5f91-9ca6-42e06fe7e79e
identifier: sec:0001528924
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# GLYNN MICHAEL

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001528924`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/df522c7a-e48e-5f91-9ca6-42e06fe7e79e  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/df522c7a-e48e-5f91-9ca6-42e06fe7e79e  

## Ownership & control

### Holdings / subsidiaries

- **SYNAGEVA BIOPHARMA CORP** (officer) — https://whiteintel.dev/entity/aabad33f-5398-5580-80ed-e469622973b8
- **PACIFIC BIOSCIENCES OF CALIFORNIA, INC.** (officer) — https://whiteintel.dev/entity/95e47b25-7575-5943-a2c4-15a6bd30c715

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **GLYNN MICHAEL**. Human view: https://whiteintel.dev/entity/df522c7a-e48e-5f91-9ca6-42e06fe7e79e · Structured JSON: https://whiteintel.dev/api/public/dossier/df522c7a-e48e-5f91-9ca6-42e06fe7e79e._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._